Ryan Crow
Senior Vice President, Investor Relations
Replay available
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2026 Earnings Call
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q1 2026 earnings conference call, held 2026-04-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Leonard Schleifer
Board Co-Chair, Co-Founder, President, and Chief Executive Officer
Dr. George Yancopoulos
Board Co-Chair, Co-Founder, President, and Chief Scientific Officer
Marion McCourt
Executive Vice President of Commercial
Chris Fenimore
Executive Vice President and Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regeneron Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.316 Welcome to the Regeneron Pharmaceuticals first quarter 2026 earnings conference call. 00:00:04.316 -- 00:00:07.060 My name is Kevin and I'll be your operator for today's call. 00:00:07.060 -- 00:00:09.302 At this time, all participants are on a listen-only mode. 00:00:09.302 -- 00:00:12.086 Later, we will conduct a question and answer session. 00:00:12.086 -- 00:00:14.068 Please note this conference is being recorded. 00:00:14.068 -- 00:00:17.132 I will now turn the call over to Ryan Crow, Senior Vice President, Investor Relations. 00:00:17.132 -- 00:00:19.372 You may begin. 00:00:19.635 -- 00:00:23.380 Thank you, Kevin. Good morning, good afternoon, and good evening to everyone listening 00:00:23.380 -- 00:00:27.364 around the world. Thank you for your interest in Regeneron and welcome to our first quarter 00:00:27.364 -- 00:00:32.574 2026 earnings conference call. An archive and transcript of this call will be available 00:00:32.574 -- 00:00:37.641 on the Regeneron Investor Relations website shortly after our call concludes. 00:00:37.641 -- 00:00:42.909 Joining me on today's call are Dr. Leonard Schleifer, Board Co-Chair, Co-Founder, President, 00:00:42.909 -- 00:00:48.336 and Chief Executive Officer, Dr. George Yancopoulos, Board Co-Chair, 00:00:48.336 -- 00:00:53.464 Co-Founder, President, and Chief Scientific Officer, Marion McCourt, Executive 00:00:53.464 -- 00:00:58.130 Vice President of Commercial, and Chris Fenimore, Executive Vice President and Chief 00:00:58.130 -- 00:01:00.376 Financial Officer. 00:01:00.376 -- 00:01:05.202 After our prepared remarks, the remaining time will be available for Q&A. 00:01:05.202 -- 00:01:08.906 I would like to remind you that remarks made on today's call may include forward-looking 00:01:0...